A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors (Q38404608)
Jump to navigation
Jump to search
scientific article published on 21 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors |
scientific article published on 21 March 2012 |
Statements
1 reference
A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors (English)
1 reference
1 reference
Diane L Reidy-Lagunes
1 reference
Efsevia Vakiani
1 reference
Michal F Segal
1 reference
Ellen M Hollywood
1 reference
Laura H Tang
1 reference
David B Solit
1 reference
M Catherine Pietanza
1 reference
Marinela Capanu
1 reference
21 March 2012
1 reference
1 reference
118
1 reference
19
1 reference
4795-4800
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference